The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Embolic Agents Market Research Report 2025
Synopsis
Embolic Agent is a material used to block off blood flow through a vessel.
The global Embolic Agents market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Embolic Agents is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Embolic Agents is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Embolic Agents include Medtronic, Terumo, Boston Scientific, Merit Medical, Johnson & Johnson, GEM Italy, IMBiotechnologies Ltd（IMB）, Emboflu and BTG, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Embolic Agents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Embolic Agents.
Report Scope
The Embolic Agents market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Embolic Agents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Embolic Agents manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medtronic
Terumo
Boston Scientific
Merit Medical
Johnson & Johnson
GEM Italy
IMBiotechnologies Ltd（IMB）
Emboflu
BTG
Cook Medical
Segment by Type
Liquid Embolic Agents
Particulate Embolic Agents
Others
Segment by Application
Occlude Bleeding
Oncotherapy
Malignant Hypertension
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Embolic Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Embolic Agents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Embolic Agent is a material used to block off blood flow through a vessel.
The global Embolic Agents market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Embolic Agents is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Embolic Agents is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Embolic Agents include Medtronic, Terumo, Boston Scientific, Merit Medical, Johnson & Johnson, GEM Italy, IMBiotechnologies Ltd（IMB）, Emboflu and BTG, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Embolic Agents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Embolic Agents.
Report Scope
The Embolic Agents market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Embolic Agents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Embolic Agents manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medtronic
Terumo
Boston Scientific
Merit Medical
Johnson & Johnson
GEM Italy
IMBiotechnologies Ltd（IMB）
Emboflu
BTG
Cook Medical
Segment by Type
Liquid Embolic Agents
Particulate Embolic Agents
Others
Segment by Application
Occlude Bleeding
Oncotherapy
Malignant Hypertension
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Embolic Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Embolic Agents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Embolic Agents Market Overview
1.1 Product Overview and Scope of Embolic Agents
1.2 Embolic Agents Segment by Type
1.2.1 Global Embolic Agents Market Value Comparison by Type (2024-2030)
1.2.2 Liquid Embolic Agents
1.2.3 Particulate Embolic Agents
1.2.4 Others
1.3 Embolic Agents Segment by Application
1.3.1 Global Embolic Agents Market Value by Application: (2024-2030)
1.3.2 Occlude Bleeding
1.3.3 Oncotherapy
1.3.4 Malignant Hypertension
1.3.5 Others
1.4 Global Embolic Agents Market Size Estimates and Forecasts
1.4.1 Global Embolic Agents Revenue 2019-2030
1.4.2 Global Embolic Agents Sales 2019-2030
1.4.3 Global Embolic Agents Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Embolic Agents Market Competition by Manufacturers
2.1 Global Embolic Agents Sales Market Share by Manufacturers (2019-2024)
2.2 Global Embolic Agents Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Embolic Agents Average Price by Manufacturers (2019-2024)
2.4 Global Embolic Agents Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Embolic Agents, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Embolic Agents, Product Type & Application
2.7 Embolic Agents Market Competitive Situation and Trends
2.7.1 Embolic Agents Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Embolic Agents Players Market Share by Revenue
2.7.3 Global Embolic Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Embolic Agents Retrospective Market Scenario by Region
3.1 Global Embolic Agents Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Embolic Agents Global Embolic Agents Sales by Region: 2019-2030
3.2.1 Global Embolic Agents Sales by Region: 2019-2024
3.2.2 Global Embolic Agents Sales by Region: 2025-2030
3.3 Global Embolic Agents Global Embolic Agents Revenue by Region: 2019-2030
3.3.1 Global Embolic Agents Revenue by Region: 2019-2024
3.3.2 Global Embolic Agents Revenue by Region: 2025-2030
3.4 North America Embolic Agents Market Facts & Figures by Country
3.4.1 North America Embolic Agents Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Embolic Agents Sales by Country (2019-2030)
3.4.3 North America Embolic Agents Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Embolic Agents Market Facts & Figures by Country
3.5.1 Europe Embolic Agents Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Embolic Agents Sales by Country (2019-2030)
3.5.3 Europe Embolic Agents Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Embolic Agents Market Facts & Figures by Country
3.6.1 Asia Pacific Embolic Agents Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Embolic Agents Sales by Country (2019-2030)
3.6.3 Asia Pacific Embolic Agents Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Embolic Agents Market Facts & Figures by Country
3.7.1 Latin America Embolic Agents Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Embolic Agents Sales by Country (2019-2030)
3.7.3 Latin America Embolic Agents Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Embolic Agents Market Facts & Figures by Country
3.8.1 Middle East and Africa Embolic Agents Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Embolic Agents Sales by Country (2019-2030)
3.8.3 Middle East and Africa Embolic Agents Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Embolic Agents Sales by Type (2019-2030)
4.1.1 Global Embolic Agents Sales by Type (2019-2024)
4.1.2 Global Embolic Agents Sales by Type (2025-2030)
4.1.3 Global Embolic Agents Sales Market Share by Type (2019-2030)
4.2 Global Embolic Agents Revenue by Type (2019-2030)
4.2.1 Global Embolic Agents Revenue by Type (2019-2024)
4.2.2 Global Embolic Agents Revenue by Type (2025-2030)
4.2.3 Global Embolic Agents Revenue Market Share by Type (2019-2030)
4.3 Global Embolic Agents Price by Type (2019-2030)
5 Segment by Application
5.1 Global Embolic Agents Sales by Application (2019-2030)
5.1.1 Global Embolic Agents Sales by Application (2019-2024)
5.1.2 Global Embolic Agents Sales by Application (2025-2030)
5.1.3 Global Embolic Agents Sales Market Share by Application (2019-2030)
5.2 Global Embolic Agents Revenue by Application (2019-2030)
5.2.1 Global Embolic Agents Revenue by Application (2019-2024)
5.2.2 Global Embolic Agents Revenue by Application (2025-2030)
5.2.3 Global Embolic Agents Revenue Market Share by Application (2019-2030)
5.3 Global Embolic Agents Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Corporation Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Embolic Agents Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Medtronic Embolic Agents Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 Terumo
6.2.1 Terumo Corporation Information
6.2.2 Terumo Description and Business Overview
6.2.3 Terumo Embolic Agents Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Terumo Embolic Agents Product Portfolio
6.2.5 Terumo Recent Developments/Updates
6.3 Boston Scientific
6.3.1 Boston Scientific Corporation Information
6.3.2 Boston Scientific Description and Business Overview
6.3.3 Boston Scientific Embolic Agents Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Boston Scientific Embolic Agents Product Portfolio
6.3.5 Boston Scientific Recent Developments/Updates
6.4 Merit Medical
6.4.1 Merit Medical Corporation Information
6.4.2 Merit Medical Description and Business Overview
6.4.3 Merit Medical Embolic Agents Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merit Medical Embolic Agents Product Portfolio
6.4.5 Merit Medical Recent Developments/Updates
6.5 Johnson & Johnson
6.5.1 Johnson & Johnson Corporation Information
6.5.2 Johnson & Johnson Description and Business Overview
6.5.3 Johnson & Johnson Embolic Agents Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Johnson & Johnson Embolic Agents Product Portfolio
6.5.5 Johnson & Johnson Recent Developments/Updates
6.6 GEM Italy
6.6.1 GEM Italy Corporation Information
6.6.2 GEM Italy Description and Business Overview
6.6.3 GEM Italy Embolic Agents Sales, Revenue and Gross Margin (2019-2024)
6.6.4 GEM Italy Embolic Agents Product Portfolio
6.6.5 GEM Italy Recent Developments/Updates
6.7 IMBiotechnologies Ltd（IMB）
6.6.1 IMBiotechnologies Ltd（IMB） Corporation Information
6.6.2 IMBiotechnologies Ltd（IMB） Description and Business Overview
6.6.3 IMBiotechnologies Ltd（IMB） Embolic Agents Sales, Revenue and Gross Margin (2019-2024)
6.4.4 IMBiotechnologies Ltd（IMB） Embolic Agents Product Portfolio
6.7.5 IMBiotechnologies Ltd（IMB） Recent Developments/Updates
6.8 Emboflu
6.8.1 Emboflu Corporation Information
6.8.2 Emboflu Description and Business Overview
6.8.3 Emboflu Embolic Agents Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Emboflu Embolic Agents Product Portfolio
6.8.5 Emboflu Recent Developments/Updates
6.9 BTG
6.9.1 BTG Corporation Information
6.9.2 BTG Description and Business Overview
6.9.3 BTG Embolic Agents Sales, Revenue and Gross Margin (2019-2024)
6.9.4 BTG Embolic Agents Product Portfolio
6.9.5 BTG Recent Developments/Updates
6.10 Cook Medical
6.10.1 Cook Medical Corporation Information
6.10.2 Cook Medical Description and Business Overview
6.10.3 Cook Medical Embolic Agents Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Cook Medical Embolic Agents Product Portfolio
6.10.5 Cook Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Embolic Agents Industry Chain Analysis
7.2 Embolic Agents Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Embolic Agents Production Mode & Process
7.4 Embolic Agents Sales and Marketing
7.4.1 Embolic Agents Sales Channels
7.4.2 Embolic Agents Distributors
7.5 Embolic Agents Customers
8 Embolic Agents Market Dynamics
8.1 Embolic Agents Industry Trends
8.2 Embolic Agents Market Drivers
8.3 Embolic Agents Market Challenges
8.4 Embolic Agents Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Embolic Agents Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Embolic Agents Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Embolic Agents Market Competitive Situation by Manufacturers in 2023
Table 4. Global Embolic Agents Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Embolic Agents Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Embolic Agents Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Embolic Agents Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Embolic Agents Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Embolic Agents, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Embolic Agents, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Embolic Agents, Product Type & Application
Table 12. Global Key Manufacturers of Embolic Agents, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Embolic Agents by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Embolic Agents as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Embolic Agents Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Embolic Agents Sales by Region (2019-2024) & (K Units)
Table 18. Global Embolic Agents Sales Market Share by Region (2019-2024)
Table 19. Global Embolic Agents Sales by Region (2025-2030) & (K Units)
Table 20. Global Embolic Agents Sales Market Share by Region (2025-2030)
Table 21. Global Embolic Agents Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Embolic Agents Revenue Market Share by Region (2019-2024)
Table 23. Global Embolic Agents Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Embolic Agents Revenue Market Share by Region (2025-2030)
Table 25. North America Embolic Agents Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Embolic Agents Sales by Country (2019-2024) & (K Units)
Table 27. North America Embolic Agents Sales by Country (2025-2030) & (K Units)
Table 28. North America Embolic Agents Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Embolic Agents Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Embolic Agents Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Embolic Agents Sales by Country (2019-2024) & (K Units)
Table 32. Europe Embolic Agents Sales by Country (2025-2030) & (K Units)
Table 33. Europe Embolic Agents Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Embolic Agents Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Embolic Agents Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Embolic Agents Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Embolic Agents Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Embolic Agents Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Embolic Agents Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Embolic Agents Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Embolic Agents Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Embolic Agents Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Embolic Agents Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Embolic Agents Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Embolic Agents Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Embolic Agents Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Embolic Agents Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Embolic Agents Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Embolic Agents Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Embolic Agents Sales (K Units) by Type (2019-2024)
Table 51. Global Embolic Agents Sales (K Units) by Type (2025-2030)
Table 52. Global Embolic Agents Sales Market Share by Type (2019-2024)
Table 53. Global Embolic Agents Sales Market Share by Type (2025-2030)
Table 54. Global Embolic Agents Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Embolic Agents Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Embolic Agents Revenue Market Share by Type (2019-2024)
Table 57. Global Embolic Agents Revenue Market Share by Type (2025-2030)
Table 58. Global Embolic Agents Price (USD/Unit) by Type (2019-2024)
Table 59. Global Embolic Agents Price (USD/Unit) by Type (2025-2030)
Table 60. Global Embolic Agents Sales (K Units) by Application (2019-2024)
Table 61. Global Embolic Agents Sales (K Units) by Application (2025-2030)
Table 62. Global Embolic Agents Sales Market Share by Application (2019-2024)
Table 63. Global Embolic Agents Sales Market Share by Application (2025-2030)
Table 64. Global Embolic Agents Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Embolic Agents Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Embolic Agents Revenue Market Share by Application (2019-2024)
Table 67. Global Embolic Agents Revenue Market Share by Application (2025-2030)
Table 68. Global Embolic Agents Price (USD/Unit) by Application (2019-2024)
Table 69. Global Embolic Agents Price (USD/Unit) by Application (2025-2030)
Table 70. Medtronic Corporation Information
Table 71. Medtronic Description and Business Overview
Table 72. Medtronic Embolic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Medtronic Embolic Agents Product
Table 74. Medtronic Recent Developments/Updates
Table 75. Terumo Corporation Information
Table 76. Terumo Description and Business Overview
Table 77. Terumo Embolic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Terumo Embolic Agents Product
Table 79. Terumo Recent Developments/Updates
Table 80. Boston Scientific Corporation Information
Table 81. Boston Scientific Description and Business Overview
Table 82. Boston Scientific Embolic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Boston Scientific Embolic Agents Product
Table 84. Boston Scientific Recent Developments/Updates
Table 85. Merit Medical Corporation Information
Table 86. Merit Medical Description and Business Overview
Table 87. Merit Medical Embolic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Merit Medical Embolic Agents Product
Table 89. Merit Medical Recent Developments/Updates
Table 90. Johnson & Johnson Corporation Information
Table 91. Johnson & Johnson Description and Business Overview
Table 92. Johnson & Johnson Embolic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Johnson & Johnson Embolic Agents Product
Table 94. Johnson & Johnson Recent Developments/Updates
Table 95. GEM Italy Corporation Information
Table 96. GEM Italy Description and Business Overview
Table 97. GEM Italy Embolic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. GEM Italy Embolic Agents Product
Table 99. GEM Italy Recent Developments/Updates
Table 100. IMBiotechnologies Ltd（IMB） Corporation Information
Table 101. IMBiotechnologies Ltd（IMB） Description and Business Overview
Table 102. IMBiotechnologies Ltd（IMB） Embolic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. IMBiotechnologies Ltd（IMB） Embolic Agents Product
Table 104. IMBiotechnologies Ltd（IMB） Recent Developments/Updates
Table 105. Emboflu Corporation Information
Table 106. Emboflu Description and Business Overview
Table 107. Emboflu Embolic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Emboflu Embolic Agents Product
Table 109. Emboflu Recent Developments/Updates
Table 110. BTG Corporation Information
Table 111. BTG Description and Business Overview
Table 112. BTG Embolic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. BTG Embolic Agents Product
Table 114. BTG Recent Developments/Updates
Table 115. Cook Medical Corporation Information
Table 116. Cook Medical Description and Business Overview
Table 117. Cook Medical Embolic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. Cook Medical Embolic Agents Product
Table 119. Cook Medical Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Embolic Agents Distributors List
Table 123. Embolic Agents Customers List
Table 124. Embolic Agents Market Trends
Table 125. Embolic Agents Market Drivers
Table 126. Embolic Agents Market Challenges
Table 127. Embolic Agents Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Embolic Agents
Figure 2. Global Embolic Agents Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Embolic Agents Market Share by Type in 2023 & 2030
Figure 4. Liquid Embolic Agents Product Picture
Figure 5. Particulate Embolic Agents Product Picture
Figure 6. Others Product Picture
Figure 7. Global Embolic Agents Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Embolic Agents Market Share by Application in 2023 & 2030
Figure 9. Occlude Bleeding
Figure 10. Oncotherapy
Figure 11. Malignant Hypertension
Figure 12. Others
Figure 13. Global Embolic Agents Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Embolic Agents Market Size (2019-2030) & (US$ Million)
Figure 15. Global Embolic Agents Sales (2019-2030) & (K Units)
Figure 16. Global Embolic Agents Average Price (USD/Unit) & (2019-2030)
Figure 17. Embolic Agents Report Years Considered
Figure 18. Embolic Agents Sales Share by Manufacturers in 2023
Figure 19. Global Embolic Agents Revenue Share by Manufacturers in 2023
Figure 20. The Global 5 and 10 Largest Embolic Agents Players: Market Share by Revenue in 2023
Figure 21. Embolic Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 22. Global Embolic Agents Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Embolic Agents Sales Market Share by Country (2019-2030)
Figure 24. North America Embolic Agents Revenue Market Share by Country (2019-2030)
Figure 25. U.S. Embolic Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Embolic Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Embolic Agents Sales Market Share by Country (2019-2030)
Figure 28. Europe Embolic Agents Revenue Market Share by Country (2019-2030)
Figure 29. Germany Embolic Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Embolic Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Embolic Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Embolic Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Embolic Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Embolic Agents Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Embolic Agents Revenue Market Share by Region (2019-2030)
Figure 36. China Embolic Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Embolic Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Embolic Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Embolic Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Embolic Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Taiwan Embolic Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Indonesia Embolic Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Thailand Embolic Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Malaysia Embolic Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Philippines Embolic Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Latin America Embolic Agents Sales Market Share by Country (2019-2030)
Figure 47. Latin America Embolic Agents Revenue Market Share by Country (2019-2030)
Figure 48. Mexico Embolic Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Brazil Embolic Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Argentina Embolic Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Middle East & Africa Embolic Agents Sales Market Share by Country (2019-2030)
Figure 52. Middle East & Africa Embolic Agents Revenue Market Share by Country (2019-2030)
Figure 53. Turkey Embolic Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia Embolic Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. U.A.E Embolic Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Global Sales Market Share of Embolic Agents by Type (2019-2030)
Figure 57. Global Revenue Market Share of Embolic Agents by Type (2019-2030)
Figure 58. Global Embolic Agents Price (USD/Unit) by Type (2019-2030)
Figure 59. Global Sales Market Share of Embolic Agents by Application (2019-2030)
Figure 60. Global Revenue Market Share of Embolic Agents by Application (2019-2030)
Figure 61. Global Embolic Agents Price (USD/Unit) by Application (2019-2030)
Figure 62. Embolic Agents Value Chain
Figure 63. Embolic Agents Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
